The First Diabetes Mellitus Conference of Ibn Al Haytham Pharma

Thursday, January 13, 2011

Ibn Al Haytham Pharma recently held its first Diabetes Mellitus conference which was attended by many endocrinologists at Lattakia Rotana hotel.

Fifty doctors attended the conference from all over Syria. The core of the scientific Lectures and the debate at the end of the conference was about DPP4 inhibitors especially Sitacretin (Sitagliptin) product which is produced by Ibn Al Haytham pharma.

DPP4 inhibitors and GLP1 Analogus are considered to be new international drugs.There are new indications that these drugs are promising and important to be used in Diabetes Mellitus treatment because of their benefits on diabetic patient.

It’s worth mentioning that Ibn Al Haytham pharma was pioneer in launching Sitagliptin (Sitacretin) in the Syrian Market for the benefit of patient.